Related Experiment Video

Updated: Oct 9, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells

M Egeblad1, O H Mortensen, L C van Kempen

  • 1Apoptosis Laboratory, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.

Biochemical and Biophysical Research Communications
|February 17, 2001
PubMed

Insights

The novel inhibitor BIBX1382BS effectively differentiates ErbB kinase signaling in cells, unlike AG1478 and PD153035. This provides a new tool for studying ErbB receptor family functions.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Pharmacology

Background:

  • ErbB tyrosine kinase receptors (ErbB1-4) regulate crucial cellular processes via ligand-induced dimerization.
  • Existing ErbB1 inhibitors, AG1478 and PD153035, show in vitro specificity but lack cellular differentiation capabilities.
  • Understanding differential ErbB receptor activity is vital for targeted therapies.

Purpose of the Study:

  • To compare the cellular efficacy of AG1478, PD153035, and a novel inhibitor, BIBX1382BS, in differentiating ErbB receptor signaling.
  • To evaluate the specificity of these inhibitors in intact cells across different ErbB activation pathways.

Main Methods:

  • Utilized intact cell assays to assess ErbB receptor signaling inhibition.
  • Compared the effects of transforming growth factor alpha (TGF-alpha), neuregulin1-beta1, and anti-ErbB2 agonist antibodies on ErbB pathways.
  • Quantified the inhibitory potency of AG1478, PD153035, and BIBX1382BS.

Main Results:

  • AG1478 and PD153035 failed to show specificity for ErbB1-mediated signaling in cells.
  • BIBX1382BS demonstrated greater potency in inhibiting TGF-alpha-induced signaling compared to other ErbB pathways.
  • BIBX1382BS selectively inhibited ErbB4 homodimer activation at lower concentrations than ErbB1 signaling.

Conclusions:

  • BIBX1382BS offers a valuable tool for discriminating between ErbB kinase activities in cellular contexts.
  • Unlike AG1478 and PD153035, BIBX1382BS allows for nuanced investigation of specific ErbB receptor signaling pathways.
  • This selectivity is crucial for advancing research in cancer biology and developing targeted therapeutics.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...